Name of Hospital Trust: Heart of England Foundation Trust Date: 2 April 2014 Drug Number of patients with Number of patients with Number of patients with Number of patients with psoriasis and psoriatic psoriasis and psoriatic psoriasis and psoriatic psoriasis and psoriatic arthropathies being treated arthropathies being treated arthropathies being treated arthropathies being treated with any of the following with any of the following with any of the following with any of the following drugs drugs receiving their drugs receiving their drugs receiving their medication from the medication via a FP10 medication through a Home Hospital Pharmacy via a (Hospital) for presentation at Healthcare Delivery Service Hospital Outpatient a Community Pharmacy prescription form Adalimimab 54 2 0 52 Golimumab 0 0 0 0 Etanercept 5 0 0 5 Infliximab 2 2 0 0 Ustekinumab 32 4 0 28
Name of Hospital Trust: Heart of England Foundation Trust Date: 2 April 2014 Drug Number of patients with psoriasis and psoriatic arthropathies being treated with any of the following drugs Number of patients with psoriasis and psoriatic arthropathies being treated with any of the following drugs receiving their medication from the Hospital Pharmacy via a Hospital Outpatient prescription form Number of patients with psoriasis and psoriatic arthropathies being treated with any of the following drugs receiving their medication via a FP10 (Hospital) for presentation at a Community Pharmacy Number of patients with psoriasis and psoriatic arthropathies being treated with any of the following drugs receiving their medication through a Home Healthcare Delivery Service Adalimimab 54 2 0 52 Golimumab 0 0 0 0 Etanercept 5 0 0 5 Infliximab 2 2 0 0 Ustekinumab 32 4 0 28
FOI-Psoriasis-and-psoriatic-arthropathies-and-rheumatoid-arthritis-replies-March-2014.docx